IceCure's ProSense Cryoablation Featured In Six Global Studies At 2024 EUSOBI Conference
IceCure's ProSense Cryoablation Featured In Six Global Studies At 2024 EUSOBI Conference
IceCure的 ProSense 冷凍消融技術在2024年EUSOBI大會上被特色板塊受邀展示了六項全球研究
ICE3 Trial Results Presented By Dr. Kenneth Tomkovich Win EUSOBI Abstract Award; THERMAC Trial Demonstrates 94% Complete Ablation Rate For Breast Cancer With Cryoablation; IceCure Conducted Hands-On Demos With Experts At Lisbon Event
ICE3 試驗結果由Kenneth Tomkovich博士介紹，贏得了EUSOBI摘要獎；THERMAC 試驗展示了乳腺癌冷凍消融的94%完全消融率；IceCure在里斯本活動中與專家們進行了親身示範
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間